SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2026-02-05 13:21Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Kaili Medical (300633), indicating a decline in net profit despite an increase in revenue [1][2] - As of February 5, 2026, Kaili Medical's stock closed at 27.27 yuan, with a slight decrease of 0.15% and a trading volume of 25,000 hands, amounting to a total transaction value of 68.20 million yuan [1] - In the recent funding flow data, the main capital saw a net inflow of 184,500 yuan, accounting for 0.27% of the total transaction value, while retail investors experienced a net outflow of 649,990 yuan, representing 9.53% of the total transaction value [1] Group 2 - For the first three quarters of 2025, Kaili Medical reported a main revenue of 1.459 billion yuan, reflecting a year-on-year increase of 4.37%, but the net profit attributable to shareholders dropped by 69.25% to 33.51 million yuan [2] - The third quarter of 2025 showed a single-quarter main revenue of 495 million yuan, up 28.42% year-on-year, but the net profit for that quarter was negative at -13.52 million yuan, indicating a year-on-year increase of 78.05% in losses [2] - The company has a debt ratio of 24.22% and a gross profit margin of 60.36%, with investment income reported at 2.08 million yuan [2]